Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis (Q44214646)

30 November 2017

Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis. (English)

1 reference

30 November 2017

Stephan Madersbacher

1

1 reference

30 November 2017

Georg Schatzl

2

1 reference

30 November 2017

Christian Bieglmayer

3

1 reference

30 November 2017

Werner J Reiter

4

1 reference

30 November 2017

Christa Gassner

5

1 reference

30 November 2017

Peter Berger

6

1 reference

30 November 2017

Thomas Zidek

7

1 reference

30 November 2017

Michael Marberger

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

60

1 reference

30 November 2017

5

1 reference

30 November 2017

869-874

1 reference

Hormones and prostate cancer: what's next?

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Carcinoma of the prostate: relationship of pretreatment hormone levels to survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Prospective study of sex hormone levels and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

High-grade prostate cancer is associated with low serum testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Familial prostatic cancer risk and low testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Effects of transurethral prostate resection and transurethral laser prostatectomy on plasma hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Effect of transurethral resection of prostate on plasma hormone levels in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Influence of radical prostatectomy on serum hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901893-9

7 January 2021

10.1016/S0090-4295(02)01893-9

Identifiers

DOI

1 reference

30 November 2017

1 reference